Viewing Study NCT06443034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-05-24 @ 10:49 AM
Study NCT ID: NCT06443034
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-05
First Post: 2024-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nephrotic Syndrome View
None Focal Segmental Glomerulosclerosis View
None APOL1 Associated Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nephrotic syndrome View
None Covid-19 associated nephropathy View
None human immunodeficiency virus associated nephropathy View
None APOL1 associated kidney disease View
None Focal segmental glomerulosclerosis View
None Minimal change disease View